Literature DB >> 33203735

Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.

Joop P Aendekerk1, Sjoerd A M E G Timmermans1, Matthias H Busch1, Judith Potjewijd1, Peter Heeringa2, Jan G M C Damoiseaux3, Chris P Reutelingsperger4, Pieter van Paassen5.   

Abstract

BACKGROUND AND OBJECTIVES: ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition of an ANCA-associated GN relapse is of importance to prevent loss of kidney function. Urinary soluble CD163 has been identified as a promising marker of active ANCA-associated GN. Previous studies, however, are limited by the lack of histologic data. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We analyzed urinary soluble CD163 in 95 patients with ANCA-associated vasculitis who underwent a kidney biopsy. In total, 125 kidney tissue sections (first kidney biopsy, n=67; repeated biopsy, n=58) with concurrent 24-hour urine samples were studied. Correlation analyses comparing urinary soluble CD163 levels and morphologic features of ANCA-associated GN were performed using Spearman rank correlation analysis. The diagnostic performance of biomarkers to detect relapsing ANCA-associated GN was evaluated using receiver operating characteristics curve analysis.
RESULTS: High levels of urinary soluble CD163 were found in 96 (87%) of 110 biopsies with active ANCA-associated GN compared with one (7%) of 15 biopsies without active ANCA-associated GN and one (6%) of 17 healthy controls. Urinary soluble CD163 correlated with fibrinoid necrosis (Rho=0.48, P<0.001) and cellular crescents (Rho=0.70, P<0.001) on kidney biopsy. In repeated biopsies, urinary soluble CD163's sensitivity of 0.94 and specificity of 0.91 for the recognition of relapsing ANCA-associated GN appeared better than routine clinical measures. The presence of CD163+ cells in affected glomeruli confirmed urinary soluble CD163's origin.
CONCLUSIONS: Urinary soluble CD163 is associated with active ANCA-associated GN and correlates with histologic features as seen in ANCA-associated GN. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_11_17_CJN07210520_final.mp3.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  ANCA; Acute kidney injury; Biopsy; glomerulonephritis; kidney biopsy; kidney pathology; macrophages; vasculitis

Mesh:

Substances:

Year:  2020        PMID: 33203735      PMCID: PMC7769013          DOI: 10.2215/CJN.07210520

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  22 in total

1.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

2.  A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Authors:  Sanjeev Sethi; Vivette D D'Agati; Cynthia C Nast; Agnes B Fogo; An S De Vriese; Glen S Markowitz; Richard J Glassock; Fernando C Fervenza; Surya V Seshan; Andrew Rule; Lorraine C Racusen; Jai Radhakrishnan; Christopher G Winearls; Gerald B Appel; Ingeborg M Bajema; Anthony Chang; Robert B Colvin; H Terence Cook; Sundaram Hariharan; Loren P Herrera Hernandez; Neeraja Kambham; Michael Mengel; Karl A Nath; Helmut G Rennke; Pierre Ronco; Brad H Rovin; Mark Haas
Journal:  Kidney Int       Date:  2017-04       Impact factor: 10.612

Review 3.  End-stage renal disease in ANCA-associated vasculitis.

Authors:  Sergey Moiseev; Pavel Novikov; David Jayne; Nikolay Mukhin
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

4.  Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry.

Authors:  Pieter van Paassen; Peter J C van Breda Vriesman; Henk van Rie; Jan Willem Cohen Tervaert
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

5.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3).

Authors:  C Mukhtyar; R Lee; D Brown; D Carruthers; B Dasgupta; S Dubey; O Flossmann; C Hall; J Hollywood; D Jayne; R Jones; P Lanyon; A Muir; D Scott; L Young; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

6.  The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

Authors:  Rennie L Rhee; John C Davis; Linna Ding; Fernando C Fervenza; Gary S Hoffman; Cees G M Kallenberg; Carol A Langford; W Joseph McCune; Paul A Monach; Philip Seo; Robert Spiera; E William St Clair; Ulrich Specks; John H Stone; Peter A Merkel
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 8.237

7.  Estimating renal survival using the ANCA-associated GN classification.

Authors:  Marc Hilhorst; Benjamin Wilde; Peter van Breda Vriesman; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

8.  Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.

Authors:  Marjan C Slot; Jan Willem Cohen Tervaert; Casper F M Franssen; Coen A Stegeman
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

9.  Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Brad H Rovin; Dawn J Caster; Daniel C Cattran; Keisha L Gibson; Jonathan J Hogan; Marcus J Moeller; Dario Roccatello; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Jürgen Floege
Journal:  Kidney Int       Date:  2019-02       Impact factor: 10.612

10.  Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Sarah M Moran; Paul A Monach; Lina Zgaga; David Cuthbertson; Simon Carette; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Christian Pagnoux; Philip Seo; Ulrich Specks; Antoine Sreih; Jason Wyse; Steven R Ytterberg; Peter A Merkel; Mark A Little
Journal:  Nephrol Dial Transplant       Date:  2020-02-01       Impact factor: 7.186

View more
  5 in total

Review 1.  Biomarkers in ANCA-Associated Vasculitis: Potential Pitfalls and Future Prospects.

Authors:  Adam D Morris; Anthony W Rowbottom; Francis L Martin; Alexander Woywodt; Ajay P Dhaygude
Journal:  Kidney360       Date:  2021-01-19

Review 2.  Acute Kidney Injury Induced by Immune Checkpoint Inhibitors.

Authors:  Ruixue Tian; Jin Liang; Rongshan Li; Xiaoshuang Zhou
Journal:  Kidney Dis (Basel)       Date:  2022-04-04

3.  Distinguishing active from quiescent disease in ANCA-associated vasculitis using attenuated total reflection Fourier-transform infrared spectroscopy.

Authors:  Adam D Morris; Camilo L M Morais; Kássio M G Lima; Daniel L D Freitas; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

4.  Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study.

Authors:  Adam D Morris; Daniel L D Freitas; Kássio M G Lima; Lauren Floyd; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin
Journal:  Molecules       Date:  2022-04-02       Impact factor: 4.411

Review 5.  Role of Macrophages and Related Cytokines in Kidney Disease.

Authors:  Elena Cantero-Navarro; Sandra Rayego-Mateos; Macarena Orejudo; Lucía Tejedor-Santamaria; Antonio Tejera-Muñoz; Ana Belén Sanz; Laura Marquez-Exposito; Vanessa Marchant; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Teresa Bellon; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  Front Med (Lausanne)       Date:  2021-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.